Wolverine Trading’s CapForce IBD 50 ETF FFTY Stock Holding History

Wolverine Trading’s Portfolio FFTY Stock Details FFTY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-10,193	Closed	-$279K	–	4756
2018 Q4	$279K	Sell	10,193 -808	-7%	-$25.1K	﹤0.01%	3274
2018 Q3	$423K	Buy	+11,001	New	+$405K	﹤0.01%	3306

Other funds holding FFTY

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CPIG

Chicago Partners Investment Group Chicago, Illinois $4.48B AUM 19.29% 1-Year Est. Return

FAAS

First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return

CCWA

CLA (CliftonLarsonAllen) Wealth Advisors Minneapolis, Minnesota $7.61B AUM 16.44% 1-Year Est. Return

Wolverine Trading's FFTY Position: Q1 2019 in Review

Wolverine Trading sold out of CapForce IBD 50 ETF (FFTY) in Q1 2019, closing a stake of 10,193 shares — an estimated $279K sold.

Wolverine Trading first reported a position in FFTY in Q3 2018 and held it in 2 quarters. The position peaked at $423K in Q3 2018. 86 funds tracked by Wall St. Rank hold FFTY as of Q1 2019.

Wolverine Trading reported no remaining CapForce IBD 50 ETF position as of Q1 2019 after selling out during the quarter.
Wolverine Trading sold 10,193 CapForce IBD 50 ETF shares in Q1 2019, an estimated $279K.
Wolverine Trading first reported a position in CapForce IBD 50 ETF in Q3 2018 and held it in 2 quarters.
Wolverine Trading's CapForce IBD 50 ETF position peaked at $423K in Q3 2018.
86 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q1 2019.

Based on Wolverine Trading's 13F filing for Q1 2019, filed 15 May 2019.